Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
A phase 1/2 trial of Trastuzumab, Pertuzumab, Oxaliplatin, Capecitabine, Ramucirumab and Bevacizumab in advanced solid tumours, run by FBD Biologics Limited, active and no longer recruiting.
Overview
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06771622 by FBD Biologics Limited, with 500 participants enrolled, started 2025-03-13 and due to reach its primary completion in 2028-01-01. Interventions recorded: HCB101, Trastuzumab, Pertuzumab, Oxaliplatin, Capecitabine and Ramucirumab.
Similar pages
not linked directly; found by shared links- TrialA Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
Shares Pertuzumab, Capecitabine, Trastuzumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Shares Oxaliplatin, Capecitabine, Bevacizumab and the tag pipeline.
- TrialA Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
Shares Pertuzumab, Trastuzumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
Shares Oxaliplatin, Capecitabine, Trastuzumab and the tag pipeline.
- TrialA Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Shares Oxaliplatin, Trastuzumab, Bevacizumab and the tag pipeline.
- TrialA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)
Shares Capecitabine, Trastuzumab, Metastatic cancer (cancer that has spread) and the tag pipeline.